| Name | Davercin |
|---|---|
| Synonyms |
Erythromycin cycloester
Carbonato ciclico de eritromicina a Eritromicina A carbonato [spanish] cyclic 11,12-cbonate erythromycin Erythromycin, cyclic 11,12-cbonate CWE Cbonato ciclico de eritromicina A [spanish] Cbonato ciclico de eritromicina a Erythromycin Impurity 50 erythromycin A cyclic 11,12-carbonate Cykliczny weglan erytromycyny A [polish] Erythromycin Impurity 10 Erythromycin Cyclocarbonate Cyclic ester erythromycin Erythromycin Cyclocbonate Erythromycin cyclocbonate (Davercin) Erythromycin Impurity 10(Davercin) Eritromicina A cbonato [spanish] Cyclic ester of erythroMycin Davercin //BP Dravercin Davercin (Erythromycin cyclocbonate) erythromycin A cyclic 11,12-cbonate Davercin, 10 mM in DMSO Erythromycin Cyclic11,12-Cbonate(Davercin) Erythromycin cyclic cbonate (1R,2R,5R,6S,7S,9R,11R,13R,14R)-8-[(2S,3R,4S,6R)-4-Dimethylamino-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-hydroxy-6-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-1,5,7,9,11,13-hexamethyl-3,15,17-trioxabicyclo[12.3.0]htadecane-4,12,16-trione (3,4R,7R,8S,9S,10R,11R,13R,15R,15-10-(((2S,3R,4S,6R)-4-(Dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-ethyl-11-hydroxy-8-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-3a,7,9,11,13,15-hexamethyloctahy Cykliczny weglan erytromycyny a Erythromycin Impurity 20(Erythromycin Cyclocbonate) Eritromicina A cbonato ErythroMycin A 11,12-cbonate, ErythroMycin A cyclic 11,12-cbonate, ErythroMycin cyclic cbonate Eritromicina A carbonato DAVERCIN |
| Description | Erythromycin Cyclocarbonate, derivative of Erythromycin, which is active against Gram-positive and some Gram-negative microorganisms. |
|---|---|
| Related Catalog | |
| Target |
Antibacterial[1] |
| In Vitro | Erythromycin is used in treatment of respiratory, gastrointestinal, and genital tract infections, as well as skin and soft tissue infections. Erythromycin, with its ten chiral centers and two sugar substituents (L-cladinose and D-desosamine), is a good starting point for numerous medicinal chemistry efforts for improvement of its biological profile (better activity, higher stability, and improved bioavailability) since the first generation of macrolides, which had low toxicity and good tolerability, are unstable in acidic media, had low toxicity and good tolerability[1]. |
| References |
| Density | 1.22 g/cm3 |
|---|---|
| Boiling Point | 859.8ºC at 760 mmHg |
| Molecular Formula | C38H65NO14 |
| Molecular Weight | 759.92100 |
| Exact Mass | 759.44100 |
| PSA | 188.98000 |
| LogP | 2.96780 |
| Index of Refraction | 1.534 |
| Storage condition | -20°C |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|